Status | Study |
Not yet recruiting |
Study Name: Effects of Infrasound Exposure on Measures of Endolymphatic Hydrops Condition: Vestibular Abnormality Endolymphatic Hydrops Date: 2017-03-09 Interventions: Other: Infrasound exposure All cohorts will receive an identical infrasound exposure of equal time durat |
Enrolling by invitation |
Study Name: A 6-Month Extension Study of OTO-104 in Meniere's Disease Condition: Meniere's Disease Date: 2016-05-09 Interventions: Drug: OTO-104 Single intratympanic injection of 12 mg OTO-104 |
Active, not recruiting |
Study Name: Open Label Study of OTO-104 in Subjects With Meniere's Disease Condition: Meniere's Disease Date: 2016-03-25 Interventions: Drug: OTO-104 Other Name: Single intratympanic injection 12 mg OTO-104 |
Completed |
Study Name: Isobide Solution and Meniace Tablets Compared to Monotherapy With Meniace Tablets Condition: Meniere's Disease Date: 2016-03-21 Interventions: Drug: Meniace 6 mg of Meniace |
Recruiting |
Study Name: Study of OTO-104 in Subjects With Unilateral Meniere's Disease Condition: Meniere's Disease Date: 2016-03-10 Interventions: Drug: OTO-104 Single intratymp |
Enrolling by invitation |
Study Name: Study to Evaluate SPI-1005 in Adults With Meniere's Disease Condition: Meniere's Disease Date: 2015-11-02 Interventions: Drug: SPI-1005 Ebselen is a small molecule mimic and inducer of glutathione peroxidase (GPx). GPx reduce |
Recruiting |
Study Name: Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Patients With Meniere's Disease Condition: Meniere's Disease Date: 2015-08-18 Interventions: Drug: Gadolinium diffusion of gadolinium for a population with Meniere's disease in order to develop an |
Recruiting |
Study Name: Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Healthy Subjects (HYDROPS) Condition: Meniere Disease Date: 2015-08-18 Interventions: Drug: Gadoteric acid Comparison with patients with Meniere's disease |
Withdrawn |
Study Name: Unilateral Meniere Disease: Can Double Dose Gadolinium and Delayed Imaging Make the Diagnosis? Condition: Meniere Disease Date: 2015-02-19 Interventions: Drug: Gadopentetate dimeglumine IV administration of 0.2 mmol/kg of Gd-DTPA |
Completed |
Study Name: A 1-Year Safety Study of OTO-104 in Subjects With Unilateral Meniere's Disease Located in United Kingdom Condition: Meniere's Disease Date: 2014-10-09 Interventions: Drug: OTO-104 Drug: Placebo |